Quote | BriaCell Therapeutics Corp. (NASDAQ:BCTX)
Last: | $2.19 |
---|---|
Change Percent: | 2.59% |
Open: | $2.26 |
Close: | $2.19 |
High: | $2.31 |
Low: | $2.19 |
Volume: | 22,628 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | BriaCell Therapeutics Corp. (NASDAQ:BCTX)
Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MD Two poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and Cristofanilli (Weill Cornell) as authors PHILADELPHIA and VANCOUVER, British Columb...
Preclinical data shows that BriaCell’s Bria-OTS+™ and Bria-PROS+™ effectively induce an anti-cancer immune response via multiple mechanisms including naïve helper and killer T cells, dendritic cells, and natural killer (NK) cells The novel mechanisms of actio...
Message Board Posts | BriaCell Therapeutics Corp. (NASDAQ:BCTX)
Subject | By | Source | When |
---|---|---|---|
$BCTX $15 Price Target | smallcapvoice | investorshub | 04/27/2023 4:15:44 PM |
BriaCell Therapeutics Corp. (Nasdaq: $BCTX, $BCTXW) was featured | smallcapvoice | investorshub | 01/30/2023 7:45:07 PM |
Strange stock, but I've loved having it the | Onree | investorshub | 01/20/2023 4:19:11 PM |
Yep, I'm still here. She's getting ready to | chenzo11 | investorshub | 06/15/2022 7:23:11 PM |
Under $4 by end of month | Nickwvt | investorshub | 04/14/2022 4:19:34 PM |
News, Short Squeeze, Breakout and More Instantly...
BriaCell Therapeutics Corp. Company Name:
BCTX Stock Symbol:
NASDAQ Market:
Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MD Two poster presentations include Drs. Hurvitz (Fred Hu...
Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MD Two poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and Cristofanilli (Weill Cornell) as authors PHILADELPHIA and VANCOUVER, British Columb...
Preclinical data shows that BriaCell’s Bria-OTS+™ and Bria-PROS+™ effectively induce an anti-cancer immune response via multiple mechanisms including naïve helper and killer T cells, dendritic cells, and natural killer (NK) cells The novel mechanisms of actio...